In follow up to the discussions held at the spring State Affiliate Council meeting, the Food and Drug Administration (FDA) expects additional releases of cisplatin from Accord Table of Contents Encourage your members to join the State Society Network Healthcare in the upcoming days. Providers and others can check on Accord supplies through their usual channels and can also contact the company directly at 866-941-7875, Option 2.

The FDA has additional information on the cisplatin shortage, including expected recovery dates from other manufacturers.

The FDA is exploring all avenues for additional supplies to ensure patient need will be met, including temporary importation. The American Society of Clinical Oncology will keep its members informed as supply becomes available.